Radnostix, Inc. (INIS)

Market Cap	31.75M +9.3%
Revenue (ttm)	11.23M -23.7%
Net Income	-2.86M
EPS	-0.01
Shares Out	529.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,190
Open	0.0600
Previous Close	0.0600
Day's Range	0.0600 - 0.0600
52-Week Range	0.0453 - 0.1100
Beta	1.22
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Radnostix

Radnostix, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally. It operates through five segments: Theranostics Products, Cobalt Products, Calibration & Reference Products, Medical Devices, and Fluorine Products. The Theranostics Products segment produces and distributes Iodine-131 generic drug product and various isotopically pure radiochemicals for medical, indu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 45
• Stock Exchange: OTCMKTS
• Ticker Symbol: INIS

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 18, 2026

Data Sources Report a data error